KC PHARMA
ActiveSummary
KC PHARMA has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €736,030 and a net result of €115,605. Equity is growing by about 4.9% per year across the filed financial years. Its solvency ranks better than 82% of 39,121 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Group and network
Connections & network
1 connected companyThe connected companies are in the list below.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
TOMKAT
via CROUX,Kathleen · Director (not named in the articles)
→